Cite
HARVARD Citation
Jain, N. et al. (2021). Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. American journal of hematology. 96 (8), pp. 1000-1007. [Online].